Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature.
Embryonal rhabdomyosarcoma (RMS) of the female genital tract usually occurs during childhood in the vagina. In rare cases, RMS can originate in the uterine cervix, with a peak incidence in the second decade. A combined modality approach to treating RMS using multidrug chemotherapy, radiotherapy, and surgery has markedly improved survival. Early stage embryonal RMS of the cervix has been found to have an excellent prognosis. The present case and literature review indicate that extensive surgery does not improve survival in patients with stage I disease.
Zeisler
H
H
Department of Gynecology and Obstetrics, University of Vienna Medical School, Austria.
Mayerhofer
K
K
Joura
E A
EA
Bancher-Todesca
D
D
Kainz
C
C
Breitenecker
G
G
Reinthaller
A
A
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D011379:Prognosis; D018233:Rhabdomyosarcoma, Embryonal / Q000473:pathology* / Q000628:therapy; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000628:therapy